Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 9.4 mg/chew; milbemycin oxime antibiotic active 1.9 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 18.8 mg/chew; milbemycin oxime antibiotic active 3.8 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 37.5 mg/chew; milbemycin oxime antibiotic active 7.5 mg/chew - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - afoxolaner; milbemycin oxime - oral bolus, chewable - afoxolaner active 150.0 mg/chew; milbemycin oxime antibiotic active 30.0 mg/chew - parasiticides

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nintedanib esilate, quantity: 180.6 mg (equivalent: nintedanib, qty 150 mg) - capsule, soft - excipient ingredients: iron oxide red; titanium dioxide; hard fat; lecithin; gelatin; glycerol; iron oxide yellow; medium chain triglycerides; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - ofev is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after failure of first line chemotherapy.,ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf).,ofev is also indicated for the treatment of other chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype.,ofev is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (ssc-ild).

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nintedanib esilate, quantity: 120.4 mg (equivalent: nintedanib, qty 100 mg) - capsule, soft - excipient ingredients: hard fat; lecithin; glycerol; iron oxide red; gelatin; medium chain triglycerides; titanium dioxide; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - ofev is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after failure of first line chemotherapy.,ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf).,ofev is also indicated for the treatment of other chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype.,ofev is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (ssc-ild).

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - bisacodyl - suppository - 5mg - bisacodyl 5mg - cathartics and laxatives

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - telmisartan; amlodipine (amlodipine besylate) - tablet - 40mg; 5mg - telmisartan 40mg; amlodipine (amlodipine besylate) 5mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - telmisartan; amlodipine (amlodipine besylate) - tablet - 40mg; 10mg - telmisartan 40mg; amlodipine (amlodipine besylate) 10mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - telmisartan; amlodipine (amlodipine besylate) - tablet - 80mg; 5mg - telmisartan 80mg; amlodipine (amlodipine besylate) 5mg - angiotensin ii receptor antagonists